GB1076219A - Parenteral iron preparations - Google Patents
Parenteral iron preparationsInfo
- Publication number
- GB1076219A GB1076219A GB4635665A GB4635665A GB1076219A GB 1076219 A GB1076219 A GB 1076219A GB 4635665 A GB4635665 A GB 4635665A GB 4635665 A GB4635665 A GB 4635665A GB 1076219 A GB1076219 A GB 1076219A
- Authority
- GB
- United Kingdom
- Prior art keywords
- mol
- complex
- solution
- iron
- carbohydrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/02—Iron compounds
- C07F15/025—Iron compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
Abstract
A non-ionic iron-carbohydrate complex is formed of 1 mol. of ferric hydroxide and 1 mol. of a complex-forming agent consisting of a mixture of sorbitol (about 0.4 mol.), gluconic acid (about 0.3 mol.) and a polyglucose (about 0.3 mol.), the polyglucose comprising dextrin, dextran, hydrogenated dextrin or hydrogenated dextran having intrinsic viscosity 0.01-0.025 at 25 DEG C., and average molecular weights 500-1200. The hydrogenated polyglucoses are substantially non-reducing to Somogyi reagent. The complex is made by treating 1 mol. of a trivalent iron compound in aqueous solution with about 2 mols. of complex-forming agent having the molar ratio of sorbitol: gluconic acid: polyglucose about 1.15: 0.40: 0.5, and heating the mixture at an alkalene pH. In one embodiment, aqueous solutions of ferric chloride and alkali are added to an aqueous solution of carbohydrate at 60 DEG C., and the reaction mixture (pH 9-9.5) heated to boiling for 5-30 minutes. Alternatively, a carbohydrate solution and alkali are added to an aqueous suspension of freshly-precipitated ferric hydroxide. In a further embodiment, an acid-complex is made by adding to aqueous ferric chloride, at room temperature, aqueous carbohydrate solution and sufficient sodium carbonate or bicarbonate solution to produce a pH of 2.5, increasing the pH to about 9.5 by addition of sodium hydroxide and heating to boiling. The complex is isolated by precipitation from the cooled and neutralized solution. The complex may contain 21-26% iron and aqueous solutions containing 5-10% iron may be formed therefrom for therapeutic use (Divisions A5-A6). The hydrogenation of dextrin is described.ALSO:A non-ionic iron-carbohydrate complex is formed of 1 mol of ferric hydroxide and 1 mol of a complex-forming agent consisting of a mixture of sorbitol (about 0.4 mol), gluconic acid (about 0.3 mol) and a polyglucose (about 0.3 mol), the polyglucose comprising dextrin, dextran, hydrogenated dextrin or hydrogenated dextran having intrinsic viscosity 0.01-0.025 at 25 DEG C., and average molecular weights 500-1200. The hydrogenated polyglucoses are substantially non-reducing to Somogyi reagent. The complex is made by treating 1 mol of a trivalent iron compound in aqueous solution with about 2 mols of complex-forming agent having the molar ratin of sorbitol : gluconic acid : polyglucose about 1.15:0.40:0.5, and heating the mixture at an alkaline pH. In one embodiment, aqueous solutions of ferric chloride and alkali are added to an aqueous solution of carbohydrate at 60 DEG C., and the reaction mixture (pH 9-9.5) heated to boiling for 5-30 minutes. Alternatively, a carbohydrate solution and alkali are added to an aqueous suspension of freshly-precipitated ferric hydroxide. In a further embodiment, an acid-complex is made by adding to aqueous carbohydrate solution and sufficient sodium carbonate or bicarbonate solution to produce a pH of 2.5, increasing the pH to about 9.5 by addition of sodium hydroxide and heating to boiling. The complex is isolated by precipitation from the cooled and neutralized solution. The complex may contain 21-26% iron and aqueous solutions containing 5-10% iron may be formed therefrom for therapeutic use (Division A5-A6). The hydrogenation of dextrin is described.ALSO:A therapeutic iron preparation comprises an aqueous solution of a non-ionic iron-carbohydrate complex formed of 1 mol of ferric hydroxide and 1 mol of a complex-forming agent consisting of a mixture of sorbitol (about 0.4 mol), gluconic acid (about 0.3 mol) and a poly glucose (about 0.3 mol), the poly-glucose comprising dextrin, dextran, hydrogenated dextrin or hydrogenated dextran having intrinsic viscosity 0.01-0.25 at 25 DEG C and average molecular weight 500-1200. The solution, which may contain 5-10% iron, are administered by intramuscular injection.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEL49194A DE1293144B (en) | 1964-11-04 | 1964-11-04 | Process for the production of complex compounds of iron with sorbitol, gluconic acid and an oligosaccharide |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1076219A true GB1076219A (en) | 1967-07-19 |
Family
ID=7272836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4635665A Expired GB1076219A (en) | 1964-11-04 | 1965-11-02 | Parenteral iron preparations |
Country Status (7)
Country | Link |
---|---|
CH (1) | CH475007A (en) |
DE (1) | DE1293144B (en) |
DK (1) | DK116688B (en) |
ES (1) | ES319085A1 (en) |
GB (1) | GB1076219A (en) |
IL (1) | IL24513A (en) |
NL (1) | NL6514241A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK172860B1 (en) * | 1998-03-25 | 1999-08-16 | Pharmacosmos Holding As | Iron dextran compound for use as a component of a therapeutic agent for the prevention or treatment of iron man |
WO2003087164A1 (en) * | 2002-04-09 | 2003-10-23 | Pharmacosmos Holding A/S | Iron dextrin compounds for the treatment of iron deficiency anaemia |
WO2005111052A1 (en) * | 2004-05-17 | 2005-11-24 | Cilag Ag | Method for producing iron (iii) gluconate complex |
JP2012521369A (en) * | 2009-03-25 | 2012-09-13 | ファーマコスモス ホールディング エー/エス | Stable iron oligosaccharide compounds |
EP2997968A1 (en) | 2014-09-22 | 2016-03-23 | Ioulia Tseti | Iron (III) hydroxide complexes with activated glucose syrups and process for preparing same |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6039681B2 (en) * | 1976-01-01 | 1985-09-07 | 日本臓器製薬株式会社 | Dextrin-citric acid-ferric polynuclear complex and parenteral iron preparation containing the complex |
HU187167B (en) * | 1982-10-15 | 1985-11-28 | Richter Gedeon Vegyeszet | Process for producing pharmaceutical solution of new type polynuclear iron/iii/ mixed complex activity |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1172250B (en) * | 1958-02-13 | 1964-06-18 | Hausmann Ag Labor | Process for the production of therapeutically usable iron (ó¾) -dextran complex compounds |
CH366537A (en) * | 1958-02-13 | 1963-01-15 | Hausmann Ag Labor | Process for the preparation of a therapeutically applicable iron-polyisomaltosate complex |
-
1964
- 1964-11-04 DE DEL49194A patent/DE1293144B/en active Pending
-
1965
- 1965-10-25 DK DK545765A patent/DK116688B/en unknown
- 1965-10-25 IL IL2451365A patent/IL24513A/en unknown
- 1965-10-29 ES ES0319085A patent/ES319085A1/en not_active Expired
- 1965-11-02 GB GB4635665A patent/GB1076219A/en not_active Expired
- 1965-11-03 NL NL6514241A patent/NL6514241A/xx unknown
- 1965-11-03 CH CH1515165A patent/CH475007A/en not_active IP Right Cessation
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK172860B1 (en) * | 1998-03-25 | 1999-08-16 | Pharmacosmos Holding As | Iron dextran compound for use as a component of a therapeutic agent for the prevention or treatment of iron man |
WO1999048533A1 (en) * | 1998-03-25 | 1999-09-30 | Pharmacosmos Holding A/S | An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition |
US6291440B1 (en) | 1998-03-25 | 2001-09-18 | Pharmacosmos Holding A/S | Iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency |
EA003427B1 (en) * | 1998-03-25 | 2003-04-24 | Фармакосмос Холдинг А/С | An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition |
KR100612071B1 (en) * | 1998-03-25 | 2006-08-11 | 파르마코스모스 홀딩 에이/에스 | An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition |
WO2003087164A1 (en) * | 2002-04-09 | 2003-10-23 | Pharmacosmos Holding A/S | Iron dextrin compounds for the treatment of iron deficiency anaemia |
JP2005530863A (en) * | 2002-04-09 | 2005-10-13 | ファーマコスモス、ホールディング、アクティーゼルスカブ | Iron dextrin compounds for the treatment of iron deficiency anemia |
CN1309741C (en) * | 2002-04-09 | 2007-04-11 | 法玛科思莫斯控股有限公司 | Iron dextrin compounds for the treatment of iron deficiency anaemia |
WO2005111052A1 (en) * | 2004-05-17 | 2005-11-24 | Cilag Ag | Method for producing iron (iii) gluconate complex |
AU2004319676B2 (en) * | 2004-05-17 | 2011-01-06 | Cilag Ag | Method for producing iron (III) gluconate complex |
JP2012521369A (en) * | 2009-03-25 | 2012-09-13 | ファーマコスモス ホールディング エー/エス | Stable iron oligosaccharide compounds |
US8815301B2 (en) | 2009-03-25 | 2014-08-26 | Pharmacosmos Holding A/S | Stable iron oligosaccharide compound |
US9439969B2 (en) | 2009-03-25 | 2016-09-13 | Pharmacosmos Holding A/S | Stable iron oligosaccharide compound |
EP3156075A1 (en) | 2009-03-25 | 2017-04-19 | Pharmacosmos Holding A/S | An oligosaccharide and a process for preparation thereof |
US10414831B2 (en) | 2009-03-25 | 2019-09-17 | Pharmacosmos Holding A/S | Stable iron oligosaccharide compound |
US10865255B2 (en) | 2009-03-25 | 2020-12-15 | Pharmacosmos Holding A/S | Stable iron oligosaccharide compound |
EP3821910A1 (en) | 2009-03-25 | 2021-05-19 | Pharmacosmos Holding A/s | An oligosaccharide and a process for preparation thereof |
US11851504B2 (en) | 2009-03-25 | 2023-12-26 | Pharmacosmos Holding A/S | Stable iron oligosaccharide compound |
EP2997968A1 (en) | 2014-09-22 | 2016-03-23 | Ioulia Tseti | Iron (III) hydroxide complexes with activated glucose syrups and process for preparing same |
EP3583941A1 (en) | 2014-09-22 | 2019-12-25 | Ioulia Tseti | Iron (iii) hydroxide complexes with activated glucose syrups and process for preparing same |
Also Published As
Publication number | Publication date |
---|---|
ES319085A1 (en) | 1966-04-16 |
IL24513A (en) | 1969-06-25 |
CH475007A (en) | 1969-07-15 |
DE1293144B (en) | 1969-04-24 |
NL6514241A (en) | 1966-05-05 |
DK116688B (en) | 1970-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Umezawa et al. | 3', 4'-Dideoxy-kanamycin B active against kanamycin-resistant Escherichia coli and Pseudomonas aeruginosa | |
Springer et al. | Common precursors of human blood group MN specificities | |
JPS6479103A (en) | External preparation | |
GB1076219A (en) | Parenteral iron preparations | |
IT1195497B (en) | PROCEDURE FOR THE PREPARATION OF OLIGOSACCHARIDIC FRACTIONS EQUIPPED WITH PHARMACOLOGICAL PROPERTIES FOR CHEMICAL DEGRADATION OF HEPARIN | |
GB1015279A (en) | Dextran compounds, methods and compositions | |
ES405961A1 (en) | Process for preparing an iron-saccharide complex | |
US3076798A (en) | Process for preparing a ferric hydroxide polymaltose complex | |
DK0480640T3 (en) | Lactoneotrehalose, its preparation and its use | |
US3629229A (en) | Water soluble basic aluminum polyhydroxyl hydrocarbon complexes | |
ES460664A1 (en) | Cerium sulfadiazine for treating burns | |
US3686397A (en) | Parenteral iron preparations | |
GB1040467A (en) | Preparation of a ferric hydroxide-hydrogenated complex | |
FR2164932A1 (en) | Alkali alpha-olefinsulphonates wetting agents - used in strongly alkaline mercerising lyes for cellulosic textiles | |
US2268780A (en) | Water-soluble sulphapyridine derivative and process of making it | |
US2453108A (en) | Carbohydrate-boric acid salts of amino aromatic bases | |
US3296246A (en) | Derivatives of antibiotics having a basic reaction and process for preparation | |
GB1088829A (en) | A process for producing ferric dextran complexes and solutions thereof for therapeutic use | |
SE329236B (en) | ||
GB1080218A (en) | Preparation of ª†-methyl glutamate and ª†-methyl glutanate hydrochloride | |
GB985206A (en) | Improvements in or relating to therapeutic iron preparation | |
KR102544469B1 (en) | Cosmetic Additives Composition and Manufacturing Method of the Same | |
US2135642A (en) | Process for the production of durable polysulphide solutions suitable for injection | |
MY104814A (en) | Improvements in or relating to dobutamine salts | |
GB1283313A (en) | Process for the production of triallyl cyanurate |